Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy

ClinicalTrials.gov

This study is currently recruiting participants. 

 

Verified April 2013 by Chinese PLA General Hospital

Sponsor:

Chinese PLA General Hospital

Information provided by (Responsible Party):

DuNan, Chinese PLA General Hospital

ClinicalTrials.gov Identifier:

NCT01838538

First received: April 19, 2013

Last updated: NA

Last verified: April 2013